Rasona, Bb Girl .
HRN: 23-96-84 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/11/2023
11/16/2023
IV
50mg
Q24
Neonatal Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes